By
Latest Stories
Don’t miss our hot and upcoming stories
Tevogen AI & Microsoft: Will Their AI & Generics Bet—and $10B Asset Strategy—Redefine U.S. Bioinnovation Infrastructure?
Key Highlights HQ Expansion to Power AI, Generics & Biosimilar VisionTevogen Bio Holdings Inc. (Nasdaq:…
AlphaMeld AI and VedTechBio: Can Their AI Alliance Cut Discovery Timelines by 50% Across 3 Liver & Metabolic Programs?
Key Highlights Strategic Alliance to Bridge AI Discovery and Translational ExecutionAlphaMeld Corporation, a global leader…
Can This AI-Driven Biotech Duo Cut Biologic Development Timelines by 40%? Axio and Likarda Bet on It
Key Highlights • AI-driven protein production from Axio BioPharma integrates with Likarda’s Core-Shell Spherification® (CSS®)…
95 Pathologists, 11 Hospitals, 1 AI Platform: Can PathAI and Northwestern Medicine Set the Standard for AI-Driven Pathology?
Key Takeaways• 95 pathologists across 11 hospitals to adopt PathAI’s AISight® digital pathology platform, enabling…